REGAIN STUDY: Retrospective Study to Assess the Effectiveness, Tolerability, and Safety of Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnant Women

Table 4

Proportion of patients with a change of ≥2 g/dl in blood hemoglobin by FCM doses.

FCM dose (mg)	Frequency				Percent
500
Less than 2	103				72.5
≥2	39				27.5
Total	142				100.0
1000
Less than 2	428				60.8
≥2	276				39.2
Total	704				100.0
1500
Less than 2	56				36.1
≥2	99				63.9
Total	155				100.0